Journal article icon

Journal article

Brexpiprazole versus placebo or other antidepressive agents for treating depression

Abstract:
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
To investigate the efficacy, tolerability, acceptability, and safety of brexpiprazole as monotherapy or adjunct treatment in the acute‐ and long‐term treatment of major depression.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1002/14651858.CD013866

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Sub department:
Psychiatry
Role:
Author
ORCID:
0000-0001-6813-8493
More by this author
Institution:
University of Oxford
Division:
MSD
Sub department:
Psychiatry
Role:
Author
ORCID:
0000-0002-2478-7763
More by this author
Institution:
University of Oxford
Division:
MSD
Sub department:
Psychiatry
Role:
Author
ORCID:
0000-0001-5179-8321


Publisher:
Cochrane Collaboration
Journal:
Cochrane Database of Systematic Reviews More from this journal
Volume:
2021
Issue:
2
Article number:
CD013866
Publication date:
2021-02-05
DOI:
EISSN:
1469-493X


Language:
English
Keywords:
Pubs id:
1169684
Local pid:
pubs:1169684
Deposit date:
2021-10-22

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP